Frequently Asked Questions about Pfizer Inc. (PFE)

Name: Pfizer Inc. (PFE) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Pfizer Inc. (PFE) do?

Accepted Answer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small mol...

Question 2

Is Pfizer Inc. (PFE) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of PFE reveals an Altman Z-Score of 2.06 and a Piotroski F-Score of 5/9. These metrics, combined with its 5-year revenue trend ($62.58B most recent), help investors decide if PFE fits their risk profile.

Question 3

What is the current P/E ratio for PFE?

Accepted Answer

As of the latest trading session, Pfizer Inc. (PFE) has a trailing P/E ratio of 20.35.

Question 4

Who is the CEO of Pfizer Inc.?

Accepted Answer

The current Chief Executive Officer of Pfizer Inc. is Albert Bourla.

Question 5

What was PFE's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Pfizer Inc. reported annual revenues of $62.58B (2025), $63.63B (2024), $59.55B (2023), $100.33B (2022), $81.29B (2021) respectively.

Question 6

Does PFE pay a dividend?

Accepted Answer

Pfizer Inc. currently pays a dividend to its shareholders, with a trailing dividend yield of 6.18%.

Question 7

How much debt and cash flow does PFE have?

Accepted Answer

In its latest reporting period, Pfizer Inc. generated $9.08B in Free Cash Flow against a total debt load of $67.42B.

Question 8

What is the Price-to-Book (P/B) ratio of Pfizer Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Pfizer Inc. (PFE) is currently 1.83.

Question 9

What is the Price-to-Sales (P/S) ratio of PFE?

Accepted Answer

Based on trailing twelve-month data, Pfizer Inc. (PFE) trades at a Price-to-Sales (P/S) ratio of 2.53.

Question 10

What is Pfizer Inc.'s Return on Equity (ROE)?

Accepted Answer

Pfizer Inc. (PFE) has a Return on Equity (ROE) of 8.67%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	11.7B	0	-2.6B	9.1B	9.1B
2024-12	12.7B	877M	-2.9B	9.8B	9B
2023-12	8.7B	525M	-3.9B	4.8B	4.3B
2022-12	29.3B	872M	-3.2B	26B	25.2B
2021-12	32.6B	1.2B	-2.7B	29.9B	28.7B

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	11.7B	0	-2.6B	9.1B	9.1B
2024-12	12.7B	877M	-2.9B	9.8B	9B
2023-12	8.7B	525M	-3.9B	4.8B	4.3B
2022-12	29.3B	872M	-3.2B	26B	25.2B
2021-12	32.6B	1.2B	-2.7B	29.9B	28.7B